Clinical Trials Directory

Trials / Terminated

TerminatedNCT01902888

Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm

Retrospective Evaluation of the GORE® VIABAHN® Endoprosthesis for a Popliteal Artery Aneurysm Indication

Status
Terminated
Phase
Study type
Observational
Enrollment
3 (actual)
Sponsor
W.L.Gore & Associates · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter, non-randomized, single arm, retrospective study of GORE® VIABAHN® Endoprosthesis for the treatment of a Popliteal Artery Aneurysm (PAA).

Detailed description

The primary objective is to evaluate the safety and efficacy of the GORE® VIABAHN® Endoprosthesis for the treatment of subjects with Popliteal Artery Aneurysms. The study population includes subjects with an asymptomatic aneurysm (≥ 2 cm diameter) of the popliteal artery, symptomatic aneurysm (no diameter requirement) of the popliteal artery, or presence of mural thrombus (no diameter requirement) of the popliteal artery treated with the GORE® VIABAHN® Endoprosthesis between January 1, 2002 and December 31, 2010. Starting with most recently treated within the above date range, patients meeting Inclusion/Exclusion will be enrolled, until a minimum of 50 subjects with adequate follow up to determine primary endpoints through 12 months will be provided.

Conditions

Interventions

TypeNameDescription
DEVICEGORE® VIABAHN® Endoprosthesis

Timeline

Start date
2013-07-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2013-07-18
Last updated
2015-06-19
Results posted
2015-06-19

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01902888. Inclusion in this directory is not an endorsement.